...
首页> 外文期刊>Journal of Inherited Metabolic Disease >Heterozygosity for an in-frame deletion causes glutaryl-CoA dehydrogenase deficiency in a patient detected by newborn screening: investigation of the effect of the mutant allele
【24h】

Heterozygosity for an in-frame deletion causes glutaryl-CoA dehydrogenase deficiency in a patient detected by newborn screening: investigation of the effect of the mutant allele

机译:框内缺失的杂合性导致新生儿筛查发现患者的戊二酰辅酶A脱氢酶缺乏症:突变等位基因影响的研究

获取原文
获取原文并翻译 | 示例
           

摘要

A patient with suspected glutaric aciduria type 1 (GA-1) was detected by newborn screening. GA-1 is known as an autosomal recessively inherited disease due to defects in the gene coding for glutaryl-CoA dehydrogenase (GCDH), a mitochondrial enzyme involved in the catabolism of the amino acids hydroxylysine, lysine and tryptophan. DNA and cDNA sequencing revealed a 18 bp deletion (c.553_570del18) resulting in deletion of six amino acids (p.Gly185_Ser190del) in one allele and no sequence changes in the other allele. Confirmatory biochemical analysis of blood, urine and cultured fibroblasts from the proband were consistent with a mild biochemical GA-1 phenotype. Recombinant expression of the mutant variant in E. coli showed that the GCDH-(p.Gly185_Ser190del) protein displayed severely decreased assembly into tetramers and enzyme activity. To discover a potential dominant negative effect of the mutant protein, we engineered a prokaryotic expression system in which expression of a wild type and a mutant GCDH allele is controlled by separately inducible promoters. These cells displayed decreased levels of GCDH tetramer and enzyme activity when expressing both the wild type and the mutant GCDH variant protein compared to the situation when only the wild type allele was expressed. Further experiments suggest that the major impact of the GCDH-(p.Gly185_Ser190del) protein in heterozygous cells consists of hampering the assembly of wild type GCDH into tetramers. Our experimental data are consistent with the hypothesis that heterozygosity for this mutation confers a dominant negative effect resulting in a GCDH enzyme activity that is significantly lower than the expected 50%.
机译:通过新生儿筛查发现疑似1型戊二酸尿症(GA-1)的患者。 GA-1由于编码戊二酰辅酶A脱氢酶(GCDH)的基因缺陷而被称为常染色体隐性遗传疾病,后者是一种参与氨基酸羟赖氨酸,赖氨酸和色氨酸分解代谢的线粒体酶。 DNA和cDNA测序显示18 bp缺失(c.553_570del18),导致一个等位基因中六个氨基酸(p.Gly185_Ser190del)缺失,而另一个等位基因中没有序列变化。对先证者的血液,尿液和培养的成纤维细胞进行的确证生化分析与轻度生化GA-1表型一致。该突变体在大肠杆菌中的重组表达表明,GCDH-(p.Gly185_Ser190del)蛋白严重降低了组装成四聚体和酶的活性。为了发现突变蛋白的潜在显性负效应,我们设计了一个原核表达系统,其中野生型和突变GCDH等位基因的表达由单独诱导的启动子控制。与仅表达野生型等位基因的情况相比,当表达野生型和突变的GCDH变体蛋白时,这些细胞显示出降低的GCDH四聚体水平和酶活性。进一步的实验表明,GCDH-(p.Gly185_Ser190del)蛋白在杂合细胞中的主要影响在于阻碍野生型GCDH组装成四聚体。我们的实验数据与以下假设相符:该突变的杂合性具有显着的负效应,导致GCDH酶活性明显低于预期的50%。

著录项

  • 来源
    《Journal of Inherited Metabolic Disease》 |2012年第5期|p.787-796|共10页
  • 作者单位

    Research Unit for Molecular Medicine, Aarhus University Hospital and Aarhus University, Institute of Clinical Medicine, Aarhus, Denmark;

    Research Unit for Molecular Medicine, Aarhus University Hospital and Aarhus University, Institute of Clinical Medicine, Aarhus, Denmark;

    Research Unit for Molecular Medicine, Aarhus University Hospital and Aarhus University, Institute of Clinical Medicine, Aarhus, Denmark;

    Research Unit for Molecular Medicine, Aarhus University Hospital and Aarhus University, Institute of Clinical Medicine, Aarhus, Denmark;

    Research Unit for Molecular Medicine, Aarhus University Hospital and Aarhus University, Institute of Clinical Medicine, Aarhus, Denmark;

    Research Unit for Molecular Medicine, Aarhus University Hospital and Aarhus University, Institute of Clinical Medicine, Aarhus, Denmark;

    Department of Clinical Genetics, Juliane Marie Center, Rigshospitalet, Copenhage;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号